0001209191-19-053427.txt : 20191017
0001209191-19-053427.hdr.sgml : 20191017
20191017163504
ACCESSION NUMBER: 0001209191-19-053427
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191015
FILED AS OF DATE: 20191017
DATE AS OF CHANGE: 20191017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sherman Matthew L
CENTRAL INDEX KEY: 0001325710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 191155467
MAIL ADDRESS:
STREET 1: C/O ACCELERON PHARMA INC
STREET 2: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-15
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001325710
Sherman Matthew L
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM
MA
02451
0
1
0
0
EVP & Chief Medical Officer
Common Stock
2019-10-15
4
A
0
35000
0.00
A
35000
D
Stock Option (Right to Buy)
34.43
2019-10-15
4
A
0
150000
0.00
A
2029-10-14
Common Stock
150000
150000
D
The reporting person was awarded 35,000 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock. The Restricted Stock Units shall vest in four (4) equal annual installments beginning on October 1, 2020, subject to the reporting person's continuous service with the Company through such dates. The Restricted Stock Units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. 25% of the options shall vest on October 1, 2020, and the remaining options shall vest in equal monthly installments over the following three years, subject to continued service through such dates.
/s/ Jeffrey M. Held, Attorney-in-Fact
2019-10-17